INTRA-CELLULAR THERAPI

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

19 نوفمبر 2024 08:00:53 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

11 نوفمبر 2024 09:45:08 بحسب NetDania Notify

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

07 نوفمبر 2024 09:48:04 بحسب NetDania Notify

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress

07 نوفمبر 2024 08:00:18 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

06 نوفمبر 2024 09:45:14 بحسب NetDania Notify

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

05 نوفمبر 2024 15:06:30 بحسب NetDania Notify

Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia

05 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

30 أكتوبر 2024 09:50:43 بحسب NetDania Notify

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

30 أكتوبر 2024 07:30:35 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

17 أكتوبر 2024 08:00:33 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

23 سبتمبر 2024 08:00:34 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

28 أغسطس 2024 08:00:04 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

08 أغسطس 2024 08:00:26 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

07 أغسطس 2024 07:40:54 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

07 أغسطس 2024 07:30:38 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

24 يوليو 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

18 يونيو 2024 07:30:16 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

10 يونيو 2024 08:00:34 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

29 مايو 2024 08:00:54 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

23 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire